FDA warned Mercola.com that website claims made its vitamin C, D3, and quercetin products unapproved COVID-19 drugs.
What happened
FDA reviewed mercola.com and mercolamarket.com on February 8, 2021, and a Twitter page that directed consumers to mercolamarket.com. FDA found Liposomal Vitamin C, Liposomal Vitamin D3, and Quercetin and Pterostilbene Advanced offered for sale with claims that they mitigate, prevent, treat, diagnose, or cure COVID-19. The claims included statements that high-dose vitamin C kills viruses and that vitamins C and D are useful for COVID-19 prevention and treatment.
What FDA found
FDA says the products are unapproved new drugs because they are sold with claims to mitigate, prevent, treat, diagnose, or cure COVID-19.
section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a)FDA says the products are misbranded drugs because their labeling makes misleading drug claims.
section 502 of the FD&C Act, 21 U.S.C. § 352FDA says introducing or delivering these products into interstate commerce is prohibited.
sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d)
What FDA wants
FDA tells the company to take immediate action to stop selling these products for COVID-19 and, within 48 hours, email COVID-19-Task-Force-CFSAN@fda.hhs.gov with the specific steps taken, supporting documents, and how it will prevent recurrence; if it cannot complete the actions in 48 hours, it must explain the delay and timetable.
Who should pay attention
- supplement brands that make health claims online
- online retailers and social media marketers of vitamin products
- regulatory teams reviewing COVID-19-related promotional claims
This is a summary. Read the original letter on fda.gov.